EZH2 and nasopharyngeal carcinoma: The results showed that the expression levels of EZH2 were significantly reduced in the miR-26a-treated mice compared with the control group (Fig. 3C and Table I), indicating that miR-26a inhibited NPC metastasis by regulating EZH2.